Excite to share the case of Romuald, the Geneva patient, the first case of durable HIV remission (32 months and counting) following allogeneic stem cell transplant with wild-type CCR5 donor cells, just published (unedited version) in @NatureMedicine.
https://t.co/xK0e2fYEgT
ACOI invita al VII Encuentro de Investigación de Inmunología, noviembre 1 y 2 en al Universidad Simón Bolívar, Barranquilla. Se abrirá convocatoria para trabajos de estudiantes no miembros de la ACOI. Pre-registro acá para miembros y no miembros 👇
https://t.co/NXX4rykjvS
ACOI invita al VII Encuentro de Investigación de Inmunología, noviembre 1 y 2 en al Universidad Simón Bolívar, Barranquilla. Se abrirá convocatoria para trabajos de estudiantes no miembros de la ACOI. Pre-registro acá para miembros y no miembros
https://t.co/XnPnjaeui0
We present the experts invited to session 1 of the "Symposium: from basic to translational science – How cutting-edge research is driving new paradigms in immunology."
Register now: https://t.co/lMnKepsy0L
Proud to see our pVISCONTI study published in @natcomms today.
https://t.co/nWpgDPLSA2
Our results shed light on the immune mechanisms associated with post-treatment HIV/SIV control.
@asiersc
Müller-Trutwin and colleagues suggest that IFN-γ regulates the persistence of SARS-CoV-2 in bronchoalveolar macrophages. Read it here: https://t.co/iLqCsC1qby
https://t.co/8QvURhZoFF
You can still register to the next session of the HIV Science online course starting on November 14. The course review different aspects of HIV by international experts in the field.
You can now register to the free online course on HIV Science from @PasteurEdu From origin to perspectives of eradication and featuring international professors. Starting date: November 14, 2023
https://t.co/9ks3kHJOSF
Terminamos la mañana de #congresoinmunoalergia con el simposio de inmunidad y terapia inmune anti-tumoral. Gracias a los expositores los doctores Paulo Rodríguez, Carlos Parra, Federico Perdomo, Paola Lasso y David Bernal
Results from the TITAN trial is out.
First of all, a huge thanks to the participants and their families for investing in these trials.
Ongiong 🧵 below..
Hoy comienza nuestro congreso en Barranquilla con el curso pre-congreso sobre revisión sistemática y metaánalisis de artículos. Acompáñenos en las redes sociales colgando sus fotos con las etiquetas #congresoinmunoalergia ¡Los esperamos¡
Controlling #HIV: @Luis_Mab @MOUQUETHugo1 ID B cell lineage of broadly neutralizing antibodies in HIV-1 post-treatment controller. Circulating viruses escaped #bNAb pressure but remained sensitive to autologous neutralization by other antibody populations https://t.co/Pn6SMTUIds
5 years is a VERY LONG time for a paper to be under review.
That was the case for our recently published paper in Nature.
Submitted in 2018 and published in 2023
What do you do as an early career researcher while waiting for a very important paper to be published ?
1/4
RT
Congreso Colombiano de Alergia, Asma e Inmunología ACAAI-ACOI en Barranquilla del 14, 15 y 16 de 2023 Simposio sobre inmunidad anti-tumoral e inmunoterapia.